Ignite Creation Date:
2024-05-05 @ 11:38 AM
Last Modification Date:
2024-10-26 @ 9:10 AM
Study NCT ID:
NCT00092742
Status:
COMPLETED
Last Update Posted:
2022-02-16
First Post:
2004-09-23
Brief Title:
Investigational Drug Versus an Approved Drug in Patients With Rheumatoid Arthritis 0663-072
Sponsor:
Organon and Co
Organization:
Organon and Co
Study Overview
Official Title:
A Randomized Double-Blind Multicenter Study to Evaluate the Tolerability and Effectiveness of Etoricoxib 90 mg qd vs Diclofenac Sodium 75 mg bid in Patients With Rheumatoid Arthritis
Status:
COMPLETED
Status Verified Date:
2022-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to evaluate the long-term safety of an investigational drug versus an approved drug for the relief of pain in patients with rheumatoid arthritis
Detailed Description:
The duration of treatment is 12 months
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 2004_055 | None | None | None |